ILOTYCIN GLUCEPTATE IV AMPOULE 646 1GM DIN 00015415
Status: Cancelled Post Market
Holder: ELI LILLY CANADA INC
Health Canada record
| Active ingredient(s) | ERYTHROMYCIN (ERYTHROMYCIN GLUCOHEPTONATE) 1 G |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01FA01 ERYTHROMYCIN |
| Original market date | 31-Dec-1957 |
| Current status date | 13-Sep-1999 |
| Source | Health Canada DPD |
Establishment licence of the holder
Eli Lilly Canada Inc. — licence 100164, currently licensed, last inspection rating C (2026-03-24).
No Canadian shortage report is currently matched to this DIN.
Request a quote for ILOTYCIN GLUCEPTATE IV AMPOULE 646 1GM